ArticleFrontiers in bioengineering and biotechnology2026
Biomechanical analysis of T10-T11 vertebrae under the combined effects of osteoporosis and L4 spondylolisthesis: a finite element analysis based on computed tomography.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Osteoporotic vertebral compression fractures are common; however, the biomechanical link between L4 spondylolisthesis and non-adjacent thoracic fractures remains unclear. This study used 3D finite element (FE) analysis to assess the biomechanical effects of L4 spondylolisthesis and osteoporosis on T10-T11. Methods: Four FE models of T10-L5 were reconstructed from CT images of a healthy adult male: normal (A), isolated spondylolisthesis (B), isolated osteoporosis (C), and combined (D). A 500-N axial load and 10-N·m moments simulated six motions. Maximum von Mises stresses of whole vertebra and cancellous bone, and segmental ROM at T10-T11, were compared. Results: L4 spondylolisthesis alone increased T10-T11 ROM (4.5%-24.7%) and stress versus normal. Osteoporosis alone markedly raised T10 overall stress (+73.9%) and cancellous stress (+19.6%) during flexion. The combined model showed the worst deterioration: peak overall stress 59.07 MPa (flexion) and cancellous stress 1.06 MPa (lateral bending). Stress nephograms confirmed concentration at the anterocentral body and pedicles, with wider distribution and higher magnitudes in pathological models. The isolated spondylolisthesis effect on stress (0.4%-15.1%) was far smaller than osteoporosis alone, and combined elevation was predominantly driven by osteoporosis. Yet synergy was most pronounced in cancellous bone-the primary load-bearing structure-where combined effects exceeded the sum of individual ones by up to 7.6 percentage points, highlighting spondylolisthesis as a critical amplifier of fracture-relevant stress in osteoporotic vertebrae. Conclusion: L4 spondylolisthesis moderately increases thoracic stress and ROM, but osteoporosis remains the main determinant of T10-T11 stress. Spondylolisthesis acts as a secondary modifier that synergistically amplifies cancellous bone stress beyond additive expectations once osteoporosis compromises vertebral strength. This synergy is the key biomechanical link between lumbar spondylolisthesis and the clinically observed rise in thoracic fracture risk. Osteoporosis worsens this effect, deteriorating the upper thoracic biomechanical environment and increasing susceptibility to secondary fractures. Clinically, concomitant lumbar spondylolisthesis in osteoporotic patients should be recognized as a key biomechanical marker for thoracic fracture risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.